These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10071783)

  • 1. Fluorescence techniques for fundamental and applied studies of membrane protein receptors: the 5-HT3 serotonin receptor.
    Hovius R; Schmid EL; Tairi AP; Blasey H; Bernard AR; Lundström K; Vogel H
    J Recept Signal Transduct Res; 1999; 19(1-4):533-45. PubMed ID: 10071783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand.
    Tairi AP; Hovius R; Pick H; Blasey H; Bernard A; Surprenant A; Lundström K; Vogel H
    Biochemistry; 1998 Nov; 37(45):15850-64. PubMed ID: 9843391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring expression and clustering of the ionotropic 5HT3 receptor in plasma membranes of live biological cells.
    Pick H; Preuss AK; Mayer M; Wohland T; Hovius R; Vogel H
    Biochemistry; 2003 Feb; 42(4):877-84. PubMed ID: 12549905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of ligand-receptor interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand.
    Wohland T; Friedrich K; Hovius R; Vogel H
    Biochemistry; 1999 Jul; 38(27):8671-81. PubMed ID: 10393542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
    Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
    Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
    Akuzawa S; Miyake A; Miyata K; Fukutomi H
    Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D; Neijt HC
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening ligands for membrane protein receptors by total internal reflection fluorescence: the 5-HT3 serotonin receptor.
    Schmid EL; Tairi AP; Hovius R; Vogel H
    Anal Chem; 1998 Apr; 70(7):1331-8. PubMed ID: 9553491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
    Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
    Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
    J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Kilpatrick GJ; Jones BJ; Tyers MB
    Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ligand-gated ion channels with the Semliki Forest virus expression system.
    Lundstrom K; Michel A; Blasey H; Bernard AR; Hovius R; Vogel H; Surprenant A
    J Recept Signal Transduct Res; 1997; 17(1-3):115-26. PubMed ID: 9029484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
    Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
    Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.